Week in Review: Seniors + MMJ, Oregon faces changes & Cannabis Caucus debuts

Bart Schaneman  | February 17, 2017

By Omar Sacirbey, Bart Schaneman and John Schroyer

A medical marijuana company in New York lands a nursing home deal, Oregon may align the state’s MMJ and recreational programs under one regulator, and the Cannabis Caucus officially launches.

Here’s a closer look at some notable developments in the marijuana industry over the past week.

New Market: Ohio medical cannabis program set to be big, but license rules could curb growth

Bart Schaneman  | February 16, 2017

By Bart Schaneman

Ohio’s medical cannabis program is expected to be large, generating upwards of $400 million in annual dispensary sales.

But possibly stringent regulations governing the number of dispensary licenses could limit patient access and curb the industry's growth potential, industry officials said.

Colorado infused products licenses skyrocket as MJ companies diversify

John Schroyer  | February 15, 2017

By John Schroyer

The number of licensed infused cannabis product manufacturers in Colorado has exploded in recent years, state records show.

The surge reflects Colorado's lack of business license caps, a resulting oversupply of marijuana, and retailers and growers diversifying into new products to boost margins in one of the nation's most competitive cannabis markets.

Cannabis reform’s future + a farewell: Q&A with outgoing DPA chief Ethan Nadelmann

John Schroyer  | February 14, 2017

By John Schroyer

Drug Policy Alliance czar Ethan Nadelmann shocked the cannabis community after announcing in late January that he's stepping down as head of the influential organization.

Many wondered how the longtime drug policy reform advocate could leave during such a tumultuous period for the industry, but he believes the timing is right for all parties.

Chart: Retail marijuana markups in Washington state continue to dip

Eli McVey  | February 13, 2017

By Eli McVey

Washington state cannabis stores continue to face pricing pressures long after the introduction of a new tax structure sent markups plunging, reflecting an increasingly competitive business environment.

Week in Review: Contaminated medical cannabis, CO workplace safety & Ohio’s tech search

Bart Schaneman  | February 10, 2017

By John Schroyer, Omar Sacirbey and Bart Schaneman

Tainted medical cannabis is suspected in a California cancer patient’s death, Colorado creates a workplace-safety guide, and Ohio is in the market for a seed-to-sale tracking system.

Here’s a closer look at some notable developments in the marijuana industry over the past week.

Future of MJ + cannabis investing under Trump: Q&A with former DEA official Jodi Avergun

John Schroyer  | February 7, 2017

By John Schroyer

If anyone has a good handle on how federal narcotics prosecutions work, it's Jodi Avergun.

She once served as chief of staff for the U.S. Drug Enforcement Administration. And now, among her duties as a partner in a Washington DC law firm, she advises clients on whether to invest in cannabis.

Chart: Arizona growing into medical marijuana juggernaut

Eli McVey  | February 6, 2017

By Eli McVey

Rather quietly, it appears, Arizona has grown into one of the largest medical cannabis markets in the nation, behind only California and Michigan in terms of patient counts.

Week in Review: Canadian exports, district attorneys policy group & dispensary lawsuit

John Schroyer  | February 3, 2017

By Omar Sacirbey, John Schroyer and Bart Schaneman

A Canadian medical marijuana company brokers another export deal, the nation’s district attorneys form a group to possibly recommend national cannabis policies, and Southern California dispensaries sue their unlicensed counterparts.

Here’s a closer look at some notable developments in the marijuana industry over the past week.

Alaska’s rec MJ rollout hampered by red tape, supply shortages

John Schroyer  | February 1, 2017

By John Schroyer

Insiders in the United States' latest recreational cannabis market - Alaska, which has been up and running since October - say the rollout has been hindered by bureaucratic issues and continued supply shortages.

Those problems are expected to be resolved in the months ahead.